All bills
H.R. 10370·119th Congress·House Bill

Ailani Myers Accelerating Innovation in Medicine to Cure Kids with Cancer Act

Stage not supplied

The source supplies the latest action, but no lifecycle stage.

Latest action (14 Sep 2026): Referred to the House Committee on Energy and Commerce.

What this bill does

H.R. 10370, also known as the Ailani Myers Accelerating Innovation in Medicine to Cure Kids with Cancer Act, aims to improve the diagnosis, treatment, and prevention of pediatric cancer. It proposes to coordinate federal efforts, including those involving advanced technologies like artificial intelligence, to advance these goals. The bill would establish a federal coordinator for AI innovation in pediatric cancer and mandate a childhood cancer data initiative within the Department of Health and Human Services. This initiative would focus on collecting, standardizing, and sharing data to improve outcomes for children with cancer.

The bill primarily affects federal agencies involved in health, research, and defense, as well as patients, survivors, families, caregivers, researchers, and entities funding pediatric cancer research. It seeks to improve data sharing and the use of artificial intelligence for better diagnosis and treatment strategies. The Department of Health and Human Services would be responsible for developing interoperability standards for patient data used with AI, prioritizing pediatric cancer cases.

This bill was introduced in the House of Representatives on September 14, 2026, and has been referred to the House Committee on Energy and Commerce. If passed by the committee, it would proceed to the House floor for consideration. If approved by the House, it would then move to the Senate for a similar process of committee referral and floor debate.

Plain-English summary generated by Bill100 AI from the official record. Always verify against the source below.

Timeline

  1. 14 Sep 2026

    Referred to the House Committee on Energy and Commerce.

Common questions

What does H.R. 10370 do?
H.R. 10370, also known as the Ailani Myers Accelerating Innovation in Medicine to Cure Kids with Cancer Act, aims to improve the diagnosis, treatment, and prevention of pediatric cancer. It proposes to coordinate federal efforts, including those involving advanced technologies like artificial intelligence, to advance these goals. The bill would establish a federal coordinator for AI innovation in pediatric cancer and mandate a childhood cancer data initiative within the Department of Health and Human Services. This initiative would focus on collecting, standardizing, and sharing data to improve outcomes for children with cancer. The bill primarily affects federal agencies involved in health, research, and defense, as well as patients, survivors, families, caregivers, researchers, and entities funding pediatric cancer research. It seeks to improve data sharing and the use of artificial intelligence for better diagnosis and treatment strategies. The Department of Health and Human Services would be responsible for developing interoperability standards for patient data used with AI, prioritizing pediatric cancer cases. This bill was introduced in the House of Representatives on September 14, 2026, and has been referred to the House Committee on Energy and Commerce. If passed by the committee, it would proceed to the House floor for consideration. If approved by the House, it would then move to the Senate for a similar process of committee referral and floor debate.
Has H.R. 10370 become law?
The source does not supply a confirmed lifecycle stage for H.R. 10370. Check the latest action and official source below.
Who sponsored H.R. 10370?
H.R. 10370 was sponsored by Rep. McCaul, Michael T. [R-TX-10] (R-TX), with 2 cosponsors.
What's the latest action on H.R. 10370?
Referred to the House Committee on Energy and Commerce. (14 Sep 2026).

Related bills in Health

More bills from Rep. McCaul, Michael T. [R-TX-10]

Bill100 mirrors the public U.S. legislative record from Congress.gov and GovTrack and adds plain-English AI summaries. It is an information tool, not legal, compliance or lobbying advice, and it is not affiliated with the U.S. Congress or any government agency. AI summaries can simplify or omit detail — every bill links to the official source; verify there before you rely on it.